Name | SMER18 |
---|---|
Synonyms |
(2Z)-1-(4-Chlorophenyl)-3-[(3-hydroxyphenyl)amino]-2-buten-1-one
(2Z)-1-(4-Chlorophenyl)-3-[(3-hydroxyphenyl)amino]but-2-en-1-one 2-Buten-1-one, 1-(4-chlorophenyl)-3-[(3-hydroxyphenyl)amino]-, (2Z)- |
Description | SMER18 is a small molecule enhancer of rapamycin which act as a mTOR-independent autophagy inducer.Target: mTORSMER18 induces autophagy independently of Rapamycin in mammalian cells, enhancing the clearance of autophagy substrates such as mutant huntingtin and A53T alpha-synuclein, which are associated with Huntington's disease and familial Parkinson's disease, respectively. SMER18 acts either independently or downstream of the target of Rapamycin, attenuates mutant huntingtin-fragment toxicity in Huntington's disease cell and Drosophila melanogaster models, which suggests therapeutic potential. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 458.7±45.0 °C at 760 mmHg |
Molecular Formula | C16H14ClNO2 |
Molecular Weight | 287.741 |
Flash Point | 231.2±28.7 °C |
Exact Mass | 287.071320 |
LogP | 3.88 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.656 |
Storage condition | 2-8℃ |